KRAS and adenoma: K-ras has also been reported in the precursor lesions IM and adenoma [12,  17,  51], yet has been shown to decrease after H. pylori eradication suggesting that H. pylori clearance therapy before the formation of stable k-ras mutations will decrease the risk of GC [52].